scorecardresearch Skip to main content
Health and biotech

Latest stories

More biotech and health care stories

EyePoint data suggest time-released drug may help patients with macular degeneration

EyePoint’s stock price vaulted more than 180 percent to $18.56 a share, a gain of $11.90 on the Nasdaq exchange in mid-day trading.


Many Americans ration insulin to save money. One nonprofit is trying to make the life-saving drug more affordable.

Eric Moyal is the founder and executive director of Project Insulin, a Providence-based nonprofit working to ensure that every American has access to affordable insulin.

Local vets urge caution but not panic over ‘mystery’ respiratory illness found in dogs

Boston-area veterinarians said they have received a surge of calls from concerned dog owners following media reports about the “mystery illness,” which in some cases has developed into pneumonia and even led to death.

FDA poised to approve first gene-editing therapy, made by local drug firms

The life-changing drug, developed by Boston-based Vertex and its Swiss partner CRISPR Therapeutics, targets sickle cell disease, an inherited blood disorder that causes crippling pain.

COVID levels in waste water edge up post-Thanksgiving

But the numbers remain low relative to this time last year.

What’s your risk of dementia? Tool from Mass. General helps assess brain health.

New research suggests a high score on measures of physical health, lifestyle, and social life translates to a lower risk of some brain diseases.

AbbVie strikes deal to acquire Waltham’s ImmunoGen for more than $10 billion

It’s the largest acquisition of a Massachusetts company this year.

Generation Bio cuts its payroll by 40 percent in latest restructuring move

The Cambridge biotech startup is seeking to extend its cash into 2027.